News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Jerel Davis
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
08/11/2023 |
4
| Jerel Davis (Director) has filed a Form 4 on CHINOOK THERAPEUTICS, INC.
Txns:
| Disposed/sold 447,013 shares
@ $0 Disposed/sold 2,105,107 shares
@ $0 Disposed/sold 719,104 shares
@ $0 Disposed/sold 210,996 shares
@ $0 Disposed/sold 23,522 options to buy
@ $14.77, valued at
$347.4k
Disposed/sold 5,948 options to buy
@ $16.81, valued at
$100k
Disposed/sold 13,300 options to buy
@ $13.88, valued at
$184.6k
|
|
07/27/2023 |
4
| Jerel Davis (10% Owner) has filed a Form 4 on Turnstone Biologics Corp.
Txns:
| Converted 2,528,864 shares
@ $0 Converted 192,458 shares
@ $0 Converted 84,313 shares
@ $0 Converted 76,067 shares
@ $0 Converted 274,990 shares
@ $0 Bought 197,458 shares
@ $12, valued at
$2.4M
Bought 15,028 shares
@ $12, valued at
$180.3k
Bought 6,575 shares
@ $12, valued at
$78.9k
Bought 5,939 shares
@ $12, valued at
$71.3k
Converted 7,897,999 preferred shares
@ $0 Converted 601,077 preferred shares
@ $0 |
|
07/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/20/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
05/31/2023 |
4
| Jerel Davis (Director) has filed a Form 4 on CHINOOK THERAPEUTICS, INC.
Txns:
| Exercised 3,300 restricted stock units
@ $0 |
|
04/19/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/03/2023 |
4
| Jerel Davis (Director) has filed a Form 4 on Repare Therapeutics Inc.
Txns:
| Disposed of 287,157 shares
@ $0 Acquired 62,026 shares
@ $0 Disposed of 8,638 shares
@ $0 Acquired 1,866 shares
@ $0 Disposed of 9,561 shares
@ $0 Acquired 2,065 shares
@ $0 Disposed of 65,957 shares
@ $0 Acquired 1,240 shares
@ $0 Disposed of 21,854 shares
@ $0 Acquired 4,721 shares
@ $0 Disposed of 4,721 shares
@ $0 |
|
12/27/2022 |
4
| Jerel Davis (Director) has filed a Form 4 on CHINOOK THERAPEUTICS, INC.
Txns:
| Disposed of 364,587 shares
@ $0 Acquired 3,600 shares
@ $0 Disposed of 108,715 shares
@ $0 Acquired 5,865 shares
@ $0 Disposed of 9,465 shares
@ $0 Acquired 1,646 shares
@ $0 |
|
12/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
09/14/2022 |
4
| Jerel Davis (Director) has filed a Form 4 on CHINOOK THERAPEUTICS, INC.
Txns:
| Disposed of 291,670 shares
@ $0 Acquired 2,878 shares
@ $0 Disposed of 86,972 shares
@ $0 Acquired 4,692 shares
@ $0 Disposed of 7,570 shares
@ $0 Acquired 1,316 shares
@ $0 Disposed of 567,963 shares
@ $0 Acquired 11,359 shares
@ $0 Disposed of 11,359 shares
@ $0 Acquired 1,975 shares
@ $0 Acquired 9,384 shares
@ $0 |
|
08/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/31/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/06/2022 |
4
| Jerel Davis (10% Owner) has filed a Form 4 on CHINOOK THERAPEUTICS, INC.
Txns:
| Disposed of 709,953 shares
@ $0 Acquired 14,194 shares
@ $0 Disposed of 14,194 shares
@ $0 Acquired 2,468 shares
@ $0 Acquired 11,726 shares
@ $0 Disposed of 11,726 shares
@ $0 |
|
03/03/2022 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
01/05/2022 |
4
| Jerel Davis (10% Owner) has filed a Form 4 on CHINOOK THERAPEUTICS, INC.
Txns:
| Sold 600,000 shares
@ $16.0002, valued at
$9.6M
Sold 308,000 shares
@ $16.0002, valued at
$4.9M
Sold 92,000 shares
@ $16.0002, valued at
$1.5M
|
|
08/31/2021 |
4
| Jerel Davis (10% Owner) has filed a Form 4 on CHINOOK THERAPEUTICS, INC.
Txns:
| Sold 510,000 shares
@ $14, valued at
$7.1M
Sold 261,902 shares
@ $14, valued at
$3.7M
Sold 78,098 shares
@ $14, valued at
$1.1M
|
|
08/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/01/2021 |
4
| Jerel Davis (10% Owner) has filed a Form 4 on Graphite Bio, Inc.
Txns:
| Converted 12,343,727 shares
@ $0 Converted 1,527,719 shares
@ $0 Bought 180,000 shares
@ $17, valued at
$3.1M
Converted 30,019,945 preferred shares
@ $0 Converted 3,715,415 preferred shares
@ $0 |
|
06/28/2021 |
4
| Jerel Davis (10% Owner) has filed a Form 4 on Graphite Bio, Inc.
Txns:
| Granted 10,000,000 preferred shares
@ $1, valued at
$10M
Granted 3,715,415 preferred shares
@ $5.06, valued at
$18.8M
Granted 40,000 options to buy
@ $17, valued at
$680k
|
|
06/24/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
06/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/19/2021 |
4
| Jerel Davis (10% Owner) has filed a Form 4 on Repare Therapeutics Inc.
Txns:
| Disposed of 153,579 shares
@ $0 Acquired 33,173 shares
@ $0 Disposed of 4,620 shares
@ $0 Acquired 998 shares
@ $0 Disposed of 5,113 shares
@ $0 Acquired 1,105 shares
@ $0 Disposed of 35,276 shares
@ $0 Acquired 1,062 shares
@ $0 Disposed of 11,688 shares
@ $0 Acquired 1,388 shares
@ $0 Disposed of 1,388 shares
@ $0 |
|
12/17/2020 |
4
| Jerel Davis (10% Owner) has filed a Form 4 on Repare Therapeutics Inc.
Txns:
| Disposed of 285,217 shares
@ $0 Disposed of 8,579 shares
@ $0 Disposed of 9,497 shares
@ $0 Disposed of 21,707 shares
@ $0 |
|
10/07/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/07/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
06/25/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|